Source:http://linkedlifedata.com/resource/pubmed/id/19139886
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-5-26
|
pubmed:abstractText |
S100A4 (metastasin 1) belongs to the S100 family of Ca(2+) binding proteins. While not present in most differentiated adult tissues, S100A4 is upregulated in the micromilieu of tumors. It is primarily expressed by tumor-associated macrophages, fibroblasts, and tumor endothelial cells. Due to its strong induction in tumors S100A4 is a promising target for cancer immunotherapy. By reverse immunology, using epitope prediction programs, we identified 3 HLA-A1-restricted peptide epitopes (S100A4 A1-1, A1-2, and A1-3) which are subject to human T cell responses as detected in peripheral blood of melanoma patients by means of IFN-gamma ELISPOT and cytotoxicity assays. In addition, IFN-gamma responses to S100A4 A1-2 can not only be induced by stimulation of T cells with peptide-loaded DC but also by stimulation with S100A4 protein-loaded DC, indicating that this epitope is indeed generated by processing of the endogenously expressed protein. In addition, S100A4 A1-2 reactive T cells demonstrate lysis of HLA-A1(+) fibroblasts in comparison to HLA-A1(-) fibroblasts. In summary, this HLA-A1-restricted peptide epitope is a candidate for immunotherapeutical approaches targeting S100A4-expressing cells in the tumor stroma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A1 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/S100 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/S100A4 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1432-0851
|
pubmed:author |
pubmed-author:AndersenMads HaldMH,
pubmed-author:BeckerJuergen CJC,
pubmed-author:BroeckerEva-BettinaEB,
pubmed-author:Hofmeister-MuellerValeskaV,
pubmed-author:LukanidinEugeneE,
pubmed-author:MederKatharinaK,
pubmed-author:SchramaDavidD,
pubmed-author:StratenPer thorP,
pubmed-author:UllrichRamonaR,
pubmed-author:Vetter-KauczokClaudia SCS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1265-73
|
pubmed:meshHeading |
pubmed-meshheading:19139886-Amino Acid Sequence,
pubmed-meshheading:19139886-Cell Line, Tumor,
pubmed-meshheading:19139886-Cells, Cultured,
pubmed-meshheading:19139886-Epitopes,
pubmed-meshheading:19139886-HLA-A1 Antigen,
pubmed-meshheading:19139886-Humans,
pubmed-meshheading:19139886-Interferon-gamma,
pubmed-meshheading:19139886-Melanoma,
pubmed-meshheading:19139886-Molecular Sequence Data,
pubmed-meshheading:19139886-Peptide Fragments,
pubmed-meshheading:19139886-S100 Proteins,
pubmed-meshheading:19139886-Sequence Alignment,
pubmed-meshheading:19139886-Skin Neoplasms,
pubmed-meshheading:19139886-T-Lymphocytes, Cytotoxic
|
pubmed:year |
2009
|
pubmed:articleTitle |
Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
|
pubmed:affiliation |
Department of Dermatology, Venerology and Allergology, University of Wuerzburg, Josef-Schneider-Strasse 2, Würzburg, Germany. Hofmeister_V@klinik.uni-wuerzburg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|